Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Zyllt 75 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Pink, round and slightly convex film-coated tablets. |
Each film-coated tablet contains 75 mg of clopidogrel (as hydrogen sulphate).
Excipients with known effect: Each film-coated tablet contains 108.125 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clopidogrel |
Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. |
| List of Excipients |
|---|
|
Tablet core: Lactose Film coating: Hypromellose (E464) |
Blister of OPA/Alu/PVC-Alu containing 7, 14, 28, 30, 50, 56, 60, 84, 90 and 100 film-coated tablets in the box.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
7 film-coated tablets: EU/1/09/553/001
14 film-coated tablets: EU/1/09/553/002
28 film-coated tablets: EU/1/09/553/003
30 film-coated tablets: EU/1/09/553/004
50 film-coated tablets: EU/1/09/553/005
56 film-coated tablets: EU/1/09/553/006
60 film-coated tablets: EU/1/09/553/007
84 film-coated tablets: EU/1/09/553/008
90 film-coated tablets: EU/1/09/553/009
100 film-coated tablets: EU/1/09/553/010
Date of first authorisation: 28 September 2009
Date of latest renewal: 14 May 2014
| Drug | Countries | |
|---|---|---|
| ZYLLT | Albania, Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
